PEOPLE - Aethlon Medical makes appointment:
This article was originally published in Clinica
Aethlon Medical (San Diego, California), a company that focuses on developing therapeutic devices for infectious diseases, has appointed Harold Handley PhD as president of the firm. Dr Handley, a co-founder of drug-discovery firm Idec (now known as Biogen), was most recently executive vice-president and chief scientific officer of Napa, California-based Transvivo, a developer of biofiltration and catheter devices.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.